Keith Thompson | Chief Executive Officer
Cell and Gene Therapy Catapult

Keith Thompson, Chief Executive Officer, Cell and Gene Therapy Catapult

Keith Thompson is the CEO of the Cell and Gene Therapy Catapult and serves on its board.
Before being named CEO in May 2012, Keith, was National Director of the Scottish National Blood Transfusion Service where he led on modernising the blood supply and expanding the service into cell therapy. Keith has also held various senior domestic and international leadership positions where he developed several bio-manufacturing businesses to become global players.

Appearances:



Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 10:00

Keynote presentation: Anticipating the technologies and infrastructure to mainstream ATMPs in the clinic

· Current technologies will get the therapies into the clinic but how are they going to become mainstream products? · What’s needed in manufacturing and supply chain? · What’s needed to ensure routine clinical adoption?

back to speakers